During the past decade, Regions Hospital Cancer Care Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 88 clinical trials were completed, i.e. on average, 800% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 18 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regions Hospital Cancer Care Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 67 trials, followed by "Eastern Cooperative Oncology Group" with 23 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "NSABP Foundation Inc" with 10 trials sponsored and "Radiation Therapy Oncology Group" with 10 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regions Hospital Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Regions Hospital Cancer Care Center" are "Breast Cancer" (33 trials), "Lung Cancer" (21 trials), "Lymphoma" (13 trials), "Esophageal Cancer" (9 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "Regions Hospital Cancer Care Center" in a lesser frequency.

Most popular intervention types in "Regions Hospital Cancer Care Center" are "Drug" (121 trials), "Biological" (51 trials), "Radiation" (32 trials), "Other" (31 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (21 trials), "bevacizumab" (17 trials), "radiation therapy" (15 trials), "cyclophosphamide" (14 trials) and "gemcitabine hydrochloride" (12 trials). Other intervention names were less common.

The vast majority of trials in "Regions Hospital Cancer Care Center" are 119 trials for "All" genders, 22 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Regions Hospital Cancer Care Center". undefined are not yet recruiting, 3 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in Regions Hospital Cancer Care Center, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Regions Hospital Cancer Care Center, 10 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".